Futura Medical refines strategy and evolves commercial model after tough 2025

Futura Medical PLC (AIM:FUM, OTC:FAMDF, FRA:GYX), the consumer healthcare company behind erectile dysfunction gel Eroxon, said it has refined its strategy...
Open original source